TokenPost·
Belite Bio Shares Fall 13% as FDA Sets New Tinlarebant Action Date

The FDA set May 12, 2027, as the new action date for tinlarebant’s application for Stargardt disease type 1.
Every crypto headline. One feed. Updated every minute.

The FDA set May 12, 2027, as the new action date for tinlarebant’s application for Stargardt disease type 1.